Search Results 221-230 of 16649 for anti-TNF drugs

1. Tetanus immune globulin (intramuscular route) - Side effects & dosage - Mayo Clinic

   Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding. Drug Interactions. Although certain medicines ...

2. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... [anti-TNF] agents) ≤ 2 weeks prior to registration. Note: Patients who have ...

3. Triamcinolone (topical application route) - Mayo Clinic

   Drug Interactions. Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an ...

4. Mayo Clinic Q and A: Risk of heart disease associated with NSAIDs

   DEAR MAYO CLINIC: Is it true that taking prescription-strength nonsteroidal anti-inflammatory drugs, or NSAIDs, can increase my risk of heart disease? How ...

5. Drugs and Supplements that Start with P - Mayo Clinic

   Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “P” to learn about drug side effects, proper use and ...

6. Monoclonal antibody drugs for cancer: How they work - Mayo Clinic

   If your health care provider recommends a monoclonal antibody drug as part of your cancer treatment, find out what to expect from this therapy. Learn enough ...

7. Diclofenac (ophthalmic route) - Side effects & dosage - Mayo Clinic

   This medicine is a topical nonsteroidal anti-inflammatory drug (NSAID). This medicine is available only with your doctor's prescription. This product is ...

8. Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer - Mayo Clinic

   anti-TNF alpha agents) =< 2 weeks prior to randomization, or anticipation of need for systemic immunosuppressive medication during study treatment, with the ...

9. Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer - Mayo Clinic

   ... anti-tumor necrosis factor [anti-TNF] agents) within 6 weeks prior to cycle 1 day 1: Patients who have received acute, low dose, systemic immunosuppressant ...

10. SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry - Mayo Clinic

    Patient is currently receiving anti-TNF treatment for ≤12 months. Patient must receive anti-TNF treatment within 2 months following enrollment into the ...